- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Most of Michigan isn't so sure what's wrong with corporate welfare, especially when their town gets a "free" grant.
But we should ask ourselves: how cozy are the Swamp and Corporate Welfare - cozy, identical, or just co-dependent?
Here's a Michigan Primer to get you started, courtesy The Midwesterner News.
@ColinJoyce
Rep. DeBoyer: MEDC hiding SOAR corporate welfare failures by renegotiating contracts
Government investment handout thus far expected to total $10.2 billion
After spending nearly $3 billion over the last dozen years, the Michigan Economic Development Corporation is working to claw back about $21.9 million in failed corporate welfare deals.
So far, the agency headed by appointees of Gov. Gretchen Whitmer has recovered roughly $18.3 million, though the MEDC is shielding other failures by renegotiating some of its biggest taxpayer-funded incentives when companies fail to meet hiring and investment metrics, according to The Detroit News.
“I think it’s important to recognize, instead of acknowledging failures, they just renegotiate the contract on what they’re able to accomplish,” state Rep. Jay DeBoyer, the Clay Twp. Republican chair of the House Oversight Committee, told the news site. “Imagine doing that with your kid when it comes to doing their chores.”
The data follows a request from DeBoyer earlier this month as his committee works to assess the performance of the state’s largest business incentive programs, which Whitmer and select lawmakers have leveraged to court big business, much of it centered on the electric vehicle industry.
The review is part of a broader effort by House Republicans to shift funding from the taxpayer-funded corporate subsidies to fulfill Whitmer’s campaign promise to “fix the damn roads.”
Records show the Michigan Business Development Program, launched in 2012, has provided 271 businesses a total of $289.8 million in incentives for an expected investment of $10.2 billion.
Sixty-two or 23% of those deals were canceled or are in repayment because grantees did not fulfill their requirements, while another 21 are in default or have declared bankruptcy. Sixty-seven, or about a quarter, were contracted last year, according to records reviewed by The News.
MEDC has identified $21.9 million in clawbacks for that program, and has collected $18.3 million so far, the MEDC told DeBoyer.
A separate Michigan Community Revitalization Program that also launched in 2012 has doled out another $365 million for 172 grants and loans to incentivize private investment in historic or brownfield sites, and the MEDC report does not detail if any are in default.
A third business incentive program created by lawmakers in 2021 known as the Strategic Outreach and Attraction Reserve committed another $2.8 billion to court massive investments in the EV and renewable energy industries. While both Ford and General Motors, the two biggest beneficiaries of SOAR funds, have scaled back their investments, Whitmer’s MEDC has not worked to claw back the funds, opting instead to renegotiate those contracts, corporation spokesman Otie McKinley told The News.
“There have been no clawback provisions triggered for SOAR projects to date,” McKinley said. “In some cases, awards have not yet been fully disbursed.”
“These latest developments underscore what I’ve been saying all along — projects like this require much stricter oversight,” said state Rep. Sarah Lightner, R-Springport. “We must have safeguards in place to protect taxpayers from financial risks and national security threats. If a project is tanking, or it turns out to have ties to a questionable company, we need the ability to claw back those funds and redirect them to better uses.”
Ford’s decision was followed by GM’s announcement in December it’s backing out of a joint venture with South Korea-based LG Energy Solution for a $2.5 billion Ultium Cells battery plant near Lansing that came with a $120 million SOAR grant.
MEDC officials ultimately cut Ford’s taxpayer cash from about $1.75 billion to between $384 and $409 million, depending on the number of jobs created, according to Bridge Michigan.
MEDC paid out GM’s SOAR grant in 2023, well before any jobs were created, and last week voted not to claw back the funding, opting instead to transfer the obligation to create 1,360 jobs to LG.
Other SOAR deals are also poised to flop, with CCP-linked Gotion, Inc. CEO Chuck Thelen announcing on Friday he halted the state permitting process to build the Gotion EV battery component plant in Mecosta County amid litigation over its fate.
Like GM and Ford, Gotion landed $715 million in taxpayer incentives from the SOAR program through secretly negotiated agreements with Whitmer’s MEDC and select lawmakers in 2022, before widespread opposition over the company’s ties to communist China derailed its plans.
The struggles at MEDC are nothing new.
A broader analysis of corporate incentive deals in Michigan from 2000 to 2020 found that out of a total of 123,060 new jobs promised, a mere 10,889 actually materialized, a success rate of just 9%.
“Only one in 11 of the announced jobs in these front page stories ever came to fruition,” according to Front Page Failures, released by the Mackinac Center for Public Policy in December 2024.
Another analysis of the first $1 billion in SOAR grant money spent found similar results, with Bridge Michigan identifying the creation of a total of 200 out of 12,000 promised jobs as of mid-June 2024.
MEDC officials argue the SOAR program hasn’t yet matured enough to effectively analyze whether it’s meeting its goal of attracting and retaining jobs in Michigan, but Boyer and his oversight committee aren’t buying it.
“The private sector measures their earnings matrix on a quarterly basis and you’re telling me the government can’t measure its matrix years down the road?” DeBoyer said. “That is messaging to conceal failures.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














